1. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-9. Extranodal NK/T-cell lymphoma, nasal type (ENKL)

   • Motoko Yamaguchi
   • Ritsuro Suzuki

   Guide Line 28 February 2019 Pages: 371 - 376

   

2. Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry

   • Hiroyuki Takamatsu
   • Takeshi Yoroidaka
   • Kosei Matsue

   Rapid Communication 18 February 2019 Pages: 377 - 381

   

3. Atypical SIFD with novel TRNT1 mutations: a case study on the pathogenesis of B-cell deficiency

   • Eri Kumaki
   • Keisuke Tanaka
   • Tomohiro Morio

   Original Article 13 February 2019 Pages: 382 - 389

   

4. Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation

   • Shoko Furukawa
   • Keiji Nogami
   • Midori Shima

   Original Article 13 February 2019 Pages: 390 - 401

   

5. Clinical features at transformation in adult T-cell leukemia–lymphoma with smoldering and chronic types

   • Hiroaki Taniguchi
   • Yoshitaka Imaizumi
   • Yasushi Miyazaki

   Original Article 24 January 2019 Pages: 402 - 408

   

6. Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study)

   • Hirokazu Murakami
   • Tetsuhiro Kasamatsu
   • Kazuyuki Shimizu

   Original Article 31 January 2019 Pages: 409 - 417

   

7. Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia

   • Nahoko Hatsumi
   • Shuichi Miyawaki
   • The Japan Adult Leukemia Study Group (JALSG)

   Original Article 06 February 2019 Pages: 418 - 425

   

8. Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system

   • Masahiro Kizaki
   • Naoto Takahashi
   • the New TARGET investigators

   Original Article 14 February 2019 Pages: 426 - 439

   

9. Optimal dosage of methotrexate for GVHD prophylaxis in umbilical cord blood transplantation

   • Yoshitaka Adachi
   • Kazutaka Ozeki
   • Akio Kohno

   Original Article 24 January 2019 Pages: 440 - 450

   

10. Prognostic values of increased B7 family proteins in haploidentical hematopoietic stem cell transplantation patients with aGVHD

    • Biqi Zhou
    • Tanzhen Wang
    • Depei Wu

    Original Article 06 February 2019 Pages: 451 - 462

    

11. Feasibility of salvage cord blood transplantation using a fludarabine, melphalan, and low-dose anti-thymocyte globulin conditioning regimen

    • Takumi Hoshino
    • Satoru Takada
    • Toru Sakura

    Original Article 08 February 2019 Pages: 463 - 469

12. Comparison of neutropenia profiles in different treatment protocols for acute myeloid leukemia using the D-index

    • Yasufumi Kawasaki
    • Shun-ichi Kimura
    • Yoshinobu Kanda

    Original Article 25 January 2019 Pages: 470 - 476

    

13. Discontinuation of l-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia

    • Ikuya Usami
    • Toshihiko Imamura
    • Japan Association of Childhood Leukemia Study Group (JACLS)

    Original Article 28 January 2019 Pages: 477 - 482

    

14. Hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma

    • Naoto Fujita
    • Ryoji Kobayashi
    • Tetsuo Mitsui

    Original Article 30 January 2019 Pages: 483 - 490

    

15. Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan

    • Nozomu Kawashima
    • Minako Iida
    • Koji Kato

    Original Article 29 January 2019 Pages: 491 - 498

    

16. A case of AITL complicated by EBV-positive B cell and monoclonal plasma cell proliferation and effectively treated with lenalidomide

    • Wataru Kishimoto
    • Yoko Takiuchi
    • Nobuyoshi Arima

    Case Report 02 January 2019 Pages: 499 - 504

    

17. Correction to: Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry

    • Hiroyuki Takamatsu
    • Takeshi Yoroidaka
    • Kosei Matsue

    Correction 21 March 2019 Pages: 505 - 505